Stockreport

UPDATE 2-U.S. FDA approves Stemline Therapeutics' rare blood disease treatment [Reuters]

STEMLINE THERAPEUTICS  (STML) 
Last stemline therapeutics earnings: 3/13 04:45 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.stemline.com/investor-relations
PDF U.S. FDA approves Stemline Therapeutics' rare blood disease treatment | Reuters 2 Min Read (Reuters) - The U.S. Food and Drug Administration on Friday approved Stemline [Read more]